These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1373175)

  • 61. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.
    Lobell A; Weissert R; Eltayeb S; de Graaf KL; Wefer J; Storch MK; Lassmann H; Wigzell H; Olsson T
    J Immunol; 2003 Feb; 170(4):1806-13. PubMed ID: 12574345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.
    Delarasse C; Daubas P; Mars LT; Vizler C; Litzenburger T; Iglesias A; Bauer J; Della Gaspera B; Schubart A; Decker L; Dimitri D; Roussel G; Dierich A; Amor S; Dautigny A; Liblau R; Pham-Dinh D
    J Clin Invest; 2003 Aug; 112(4):544-53. PubMed ID: 12925695
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis.
    Johns TG; Kerlero de Rosbo N; Menon KK; Abo S; Gonzales MF; Bernard CC
    J Immunol; 1995 May; 154(10):5536-41. PubMed ID: 7537310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.
    Dyer CA
    Mol Neurobiol; 1993; 7(1):1-22. PubMed ID: 8391270
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells.
    Kap YS; Smith P; Jagessar SA; Remarque E; Blezer E; Strijkers GJ; Laman JD; Hintzen RQ; Bauer J; Brok HP; 't Hart BA
    J Immunol; 2008 Feb; 180(3):1326-37. PubMed ID: 18209026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily.
    Gardinier MV; Amiguet P; Linington C; Matthieu JM
    J Neurosci Res; 1992 Sep; 33(1):177-87. PubMed ID: 1453482
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Endogenous cerebellar soluble lectin and its ligands in central nervous system myelin of quaking and jimpy mutant mice.
    Kuchler S; Zanetta JP; Zaepfel M; Badache A; Sarliève LL; Gumpel M; Baumann N; Vincendon G
    Dev Neurosci; 1990; 12(6):382-97. PubMed ID: 2076671
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The structure and function of myelin oligodendrocyte glycoprotein.
    Johns TG; Bernard CC
    J Neurochem; 1999 Jan; 72(1):1-9. PubMed ID: 9886048
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An antisense transgenic strategy to inhibit the myelin oligodendrocyte glycoprotein synthesis.
    Jaquet V; Gow A; Tosic M; Suchanek G; Breitschopf H; Lassmann H; Lazzarini RA; Matthieu JM
    Brain Res Mol Brain Res; 1996 Dec; 43(1-2):333-7. PubMed ID: 9037550
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of N-glycan in folding, trafficking and pathogenicity of myelin oligodendrocyte glycoprotein (MOG).
    Jung J; Dudek E; Michalak M
    Biochim Biophys Acta; 2015 Sep; 1853(9):2115-21. PubMed ID: 25541284
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
    Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
    J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glycosylation of bombesin receptors: characterization, effect on binding, and G-protein coupling.
    Kusui T; Benya RV; Battey JF; Jensen RT
    Biochemistry; 1994 Nov; 33(44):12968-80. PubMed ID: 7947701
    [TBL] [Abstract][Full Text] [Related]  

  • 77. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
    Linington C; Berger T; Perry L; Weerth S; Hinze-Selch D; Zhang Y; Lu HC; Lassmann H; Wekerle H
    Eur J Immunol; 1993 Jun; 23(6):1364-72. PubMed ID: 7684687
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
    J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of a basolateral membrane targeting signal within the cytoplasmic domain of myelin/oligodendrocyte glycoprotein.
    Kroepfl JF; Gardinier MV
    J Neurochem; 2001 Jun; 77(5):1301-9. PubMed ID: 11389181
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.